Elite Pharmaceuticals Inc (ELTP)

[freegriff]

much ado about nothing. We did a lot of R&D. We saw the iffy results. We're sitting on a boatload of raw materials that we aren't converting at an aggressive rate. Maybe that was due to anticipating all these SunGen deals or that the Tmax data might be definitively good. But that's worrisome. I now also want to know the shelf life of that $5M of raw goods. No evidence of generic growth here, but not of shrinkage either. Same story, getting out of the business of contract manufacturing.

We have to hear about SequestOx progress. That is all. This 10Q is a bland report. Nothing good or bad. The company is floating until we can move on SequestOx or something else.